We have also observed nuclear mTOR expression in tumor cells, feature previously reported in solitary fibrous tumors, the same as EGFR expression abnormalities [8, 9], potential targets for orienting drug treatments for nasal glomangiopericytomas, especially when occurring at advanced ages or requiring complex surgery. The gene discussed is EGFR; the disease is neoplasm.